News

Latest News:

MC2 Therapeutics A/S announces completion of recruitment in Phase 2 study in moderate-to-severe dry eye disease with MC2-03

POSTED: November 9, 2017

  • Completion of patient recruitment meeting randomization target of 264 patients
  • Topline results are expected in 2018

 Copenhagen, November 9th, 2017 – MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today ...

READ FULL ARTICLE >

mc2_news-image-icon-04

MC2 Therapeutics A/S announces first patient dosed in pivotal US Phase 3 trial in psoriasis vulgaris

POSTED: October 9, 2017

  • First patient dosed in the pivotal Phase 3 trial assessing the safety and efficacy of MC2-01 Cream in US
  • Topline results are expected in Q3 2018

Copenhagen, October 9th, 2017 – MC2 ...

READ FULL ARTICLE >

MC2 Therapeutics A/S appoints Anders D. Hove and Paul L. Berns to the Board of Directors

POSTED: August 1, 2017

Copenhagen, August, 2017 – MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company, has appointed Dr. Anders D. Hove and Mr. Paul L. Berns to serve on the Board.

“On ...

READ FULL ARTICLE >

MC2 Therapeutics to present data at the 2017 ARVO Annual Meeting highlighting the therapeutic potential of PAD ® Techno.

POSTED: May 1, 2017

Copenhagen, February 24th, 2017 – MC2 Therapeutics today announced that two abstracts were accepted for poster presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting ...

READ FULL ARTICLE >

Events:

February 28th - 29th, 2024

MC2 Therapeutics to present at the 17th Annual European Life Sciences CEO Forum

READ MORE >

November 14th - 16th, 2023

Meet MC2 at Jefferies London Healthcare Conference

READ MORE >

May 15th - 16th, 2023

MC2 Therapeutics to present at Bio€quity Europe 2023

READ MORE >

February 7th, 2023

MC2 Therapeutics to present at the BIO CEO & Investor Conference in NYC

READ MORE >

January 9th - 12th, 2023

J.P. Morgan Healthcare Conference 2023 (San Francisco)

READ MORE >

January 8th, 2023

MC2 Therapeutics to present at the Dermatology Summit 2023 in San Francisco

READ MORE >

December 7th, 2022

MC2 Therapeutics to present at Carnegie’s Next Generation Nordic Life Science Champions Seminar 2022

READ MORE >

November 15th - 17th, 2022

MC2 Therapeutics attends the Jefferies London Healthcare Conference

READ MORE >

February 28th, 2022

MC2 exposure at PCMA Business Forum 2022

READ MORE >

August 11th, 2021

MC2 Therapeutics is proud to support National Psoriasis Action Month

READ MORE >

July 23, 2021

MC2 Therapeutics supports World Sjögren’s Day

READ MORE >